Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone for kidney protection during cardiac procedures
NCT01391520Phase 3Withdrawn
- Sponsor
- CorMedix Inc.
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in acute kidney injury (AKI) comparing Deferiprone Arm with Placebo Arm (2 arms). Primary endpoint: A composite of renal and cardiovascular clinical events occurring through Day 90. Planned start Jan 2012; status: withdrawn.
02
Drugs
deferiprone
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01391520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391520.